QUALITY OF LIFE AND UTILITY DECREMENT ASSOCIATED WITH CLOSTRIDIUM DIFFICILE INFECTION IN FRENCH ACUTE CARE FACILITIES
Author(s)
Fagnani F1, Duburcq A1, Galperine T2, Vanhems P3, Le Monnier A4, Alami S5, Bensoussan C6, Jeanbat V1, Barbut F7
1CEMKA-EVAL, Bourg la Reine, France, 2CHU Lille, Lille, France, 3Hospices Civils de Lyon, Lyon, France, 4Groupement hospitalier Paris Saint-Joseph, Paris, France, 5MSD France, Courbevoie, France, 6MSD France, Coubevoie, France, 7Laboratory for Clostridium Difficile, Paris, France
OBJECTIVES: To estimate the impact on quality of life and the QALY decrement associated with Clostridium difficile infection (CDI) in the hospital setting. METHODS: An observational prospective study was performed in 7 French acute-care facilities in 2016 where patients presenting with a bacteriologically-confirmed CDI were randomly enrolled. The EQ-5D-3L was filled in by patients at 7 (+/-2) days after CDI diagnosis to describe their perceived state of health at that date and also to retrospectively assess their state of health as of immediately before the episode (baseline). Individual utility decrement was obtained by subtracting the corresponding utilities using the French tariffs. The QALY loss was calculated by multiplying the days spent from baseline (first symptoms) to the date of the interview, by the decrement of utility. A multivariate analysis of variance of the utility decrement according to CDI and patients and infection characteristics was performed. RESULTS: CONCLUSIONS: The impact on quality of life of CDI episodes aside from the consequence of excess mortality is major and translates in a substantial QALY loss despite their short duration.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PIN78
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Infectious Disease (non-vaccine)